Dr. Bjork is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
850 W Baraga Ave
Marquette, MI 49855
Summary
- Dr. Jonathan Bjork is a dedicated healthcare professional specialising in Internal Medicine, with a subspecialty focus on Hospital Medicine. Based in Marquette, MI, he received his medical degree from Emory University School of Medicine in 2016, followed by a residency at the University of Minnesota. Since 2019, he has been employed as a Hospitalist at UP Health System Marquette. In addition to his clinical work, Dr. Bjork has contributed to the medical field through various publications. His research, primarily related to heart failure and pharmacogenetics, has been published in respected journals and widely cited by fellow researchers within the medical community.
Education & Training
University of MinnesotaResidency, Internal Medicine, 2016 - 2019
Emory University School of MedicineClass of 2016
Certifications & Licensure
MI State Medical License 2019 - 2026
MN State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 34 citationsDefining Advanced Heart Failure: A Systematic Review of Criteria Used in Clinical TrialsJonathan B. Bjork, Kristina K. Alton, Vasiliki V. Georgiopoulou, Javed Butler, Andreas P. Kalogeropoulos
Journal of Cardiac Failure. 2016-07-01 - 54 citationsProgression to Stage D Heart Failure Among Outpatients With Stage C Heart Failure and Reduced Ejection FractionAndreas P. Kalogeropoulos, Ayman Samman-Tahhan, Jeffrey Hedley, Andrew A. McCue, Jonathan B. Bjork
JACC. Heart Failure. 2017-07-01 - 3 citationsHLA-B*58: 01 carrier status of Hmong in Minnesota: first in Hmong genotyping for prevalence of this biomarker of risk for severe cutaneous adverse reactions caused by ...Kerui Peng, Jonathan B. Bjork, Ya Feng Wen, Youssef M Roman, Kathleen A. Culhane-Pera
Pharmacogenetics and Genomics. 2020-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
